Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01460329 · ClinicalTrials.gov registry record

Comparing Cardiac Output Measurements in Critically Ill Children Using USCOM and Transthoracic ECHO

A clinical trial of Critical Illness and Pediatrics, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
22
Enrollment target
1
Study location

NCT01460329: Completed study of Critical Illness and Pediatrics, sponsored by University of North Carolina, Chapel Hill.

NCT01460329 is a study of Critical Illness and Pediatrics that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 22 participants, below the 3,138-participant average among 91 other Critical Illness trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01460329, a study of Critical Illness and Pediatrics, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
22 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the accuracy and precision of two non-invasive methods of measuring cardiac output in critically ill children (\<18 yrs). The participants will include any patient admitted to Pediatric intensive care unit (PICU) requiring a trans-thoracic ECHO (TTE) as part of their treatment plan. Measurements of intermittent cardiac output will be obtained and compared on participants using standard 2-D TTE and Ultrasound Cardiac Output Monitor (USCOM).

Interventions

  • DEVICE Ultrasonic Cardiac Output Monitor (USCOM).

Study Locations (1)

North Carolina

  • UNC Children's Hospital - Chapel Hill

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2011-10
Est. Completion 2012-06

What the finished NCT01460329 record still lists

NCT01460329 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 3,138-participant average among 91 other Critical Illness trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 1 intervention - of which Ultrasonic Cardiac Output Monitor (USCOM). is the first listed.

NCT01460329 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT01460329 about?

NCT01460329 is a clinical study titled "Comparing Cardiac Output Measurements in Critically Ill Children Using USCOM and Transthoracic ECHO". The purpose of this study is to compare the accuracy and precision of two non-invasive methods of measuring cardiac output in critically ill children (\<18 yrs). The participants will include any patient admitted to Pediatric intensive care unit (PICU) requiring a trans-thoracic ECHO (TTE) as part o...

What is the current status of trial NCT01460329?

This trial is currently completed. The enrollment target is 22 participants. The study started on 2011-10. Estimated completion is 2012-06.

What conditions does trial NCT01460329 study?

This clinical trial studies the following conditions: Critical Illness, Pediatrics.

What interventions are being tested in trial NCT01460329?

The interventions under investigation include: Ultrasonic Cardiac Output Monitor (USCOM). (DEVICE).

Who is sponsoring clinical trial NCT01460329?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01460329 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01460329's enrollment target sits among peer trials

22 89th of 91 higher than 3 of 91 other Critical Illness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01460329, the US trial registry maintained by the National Library of Medicine. NCT01460329 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.